Trans-European cooperation and coordination of genome sequencing and functional genomics of human-pathogenic microorganisms Duration: 2004-2008
The ERA-NET "Pathogenomics" was launched in October 2004 as a European network designed to coordinate national research activities in the field of genomic research and to create joint funding programmes. In recent years, genomics has revolutionised medical research, especially the study of pathogenic micro-organisms. However, in contrast to human genome research, for which considerable international funding and coordination activities have been undertaken, the funding and organisation of pathogenomics research programmes are still largely fragmented in Europe. PathoGenoMics was founded in order to improve this situation. It creates a central platform which allows programme managers, government policymakers and other involved parties to design joint activities. The consortium includes representatives from 11 core countries. In addition, the network includes seven associated countries which currently do not carry out funding activities in the field of pathogenomics.
Germany: Forschungszentrum Jülich GmbH; Austria: Federal Ministry of Education, Science and Culture; Finland: Academy of Finland (AKA); France: Ministry of Research, Department for Bio-Engineering; Germany: Federal Ministry of Education and Research; Hungary: National Office of Research and Technology; Israel: Chief Scientist Office, Israeli Ministry of Health; Latvia: Latvian Council of Science; Portugal: Portuguese National Science Foundation; Slovenia: Ministry of Education, Science and Sport; Spain: Ministry of Education and Science; Austria: Austrian Science Fund (FWF); Lithuania: Ministry of Education and Science; Malta: Malta Council for Science and Technology; Netherlands: Netherlands Genomics Initiative; Norway: Research Council of Norway; Sweden: Swedish Foundation for Strategic Research; United Kingdom: Biotechnology and Biological Sciences Research Council; United Kingdom: Wellcome Trust, Infection and Immunity Programme
Role of the FWF
Active participation in project meetings
Status of the FWF